Drug Information

Drug General Information
Drug ID
D05EMG
Former ID
DIB003425
Drug Name
Butylscopolamine
Drug Type
Small molecular drug
Indication Dysmenorrhea [ICD9: 625.3; ICD10:N94.4-N94.6] Approved [551871]
Structure
Download
2D MOL

3D MOL
Formula
C21H30NO4+
Canonical SMILES
CCCC[N+]1(C)[C@@H]2C[C@H](C[C@H]1[C@@H]3O[C@H]23)OC(=O)<br />[C@H](CO)c4ccccc4
InChI
1S/C21H30NO4/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14/h5-9,15-20,23H,3-4,10-13H2,1-2H3/q+1/t15-,16-,17-,18+,19-,20+,22?/m1/s1
InChIKey
YBCNXCRZPWQOBR-WVHCHWADSA-N
PubChem Compound ID
656588
Target and Pathway
Target(s) Acetylcholine receptor Target Info Modulator [533864], [551871]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Muscarinic acetylcholine receptors
Acetylcholine regulates insulin secretion
Highly sodium permeable acetylcholine nicotinic receptors
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
WikiPathways Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 533864Comparison of pharmacological effects of L- and DL-n-butyl-scopolamine in rat uterus. Yao Xue Xue Bao. 1994;29(1):24-7.
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.